Trademarkia Logo

Australia

AU$
ALYFTREO
Protected: Registered/protected

Last updated on 30 Jul 2020

Owner Info

Vertex Pharmaceuticals Incorporated

50 Northern Avenue

Boston MA 02210, UNITED STATES OF AMERICA

Serial Number

1962832 filed on 28 Jul 2018

Correspondent

Timothy H. Hiebert

Womble Bond Dickinson (US) LLP,

470 Atlantic Avenue, Suite 600,

UNITED STATES OF AMERICA

ALYFTREO

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cystic fibrosis

Mark Details


Serial Number

1962832

Registered On

28 Jul 2018

Renewal On

28 Jul 2028

Mark Type

FIGURATIVE

Priority Claim (Convention Details)


Date

16 May 2018

Mark Type

US

Legal History


Show more

Status DateAction Taken
30th Jul 2020Amendment to International Registration Contact Requested
1st May 2019IP Right Registration Published
1st May 2019International Registration in Australia Protected correspondence sent
1st May 2019Status change to Registered/Protected
21st Feb 2019Application Accepted correspondence sent
21st Feb 2019IP Right Acceptance Published
21st Feb 2019IP Right has been Examined
21st Feb 2019Status change to Accepted
25th Oct 2018IP Right Filed Published
22nd Oct 2018Application Status